Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
Cantor Fitzgerald
Chubb
Chinese Patent Office
Farmers Insurance

Generated: August 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208204

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 208204 describes BETAMETHASONE VALERATE, which is a drug marketed by Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Sti Pharma Llc, Teva Pharms, and Actavis Mid Atlantic, and is included in eighteen NDAs. It is available from fourteen suppliers. Additional details are available on the BETAMETHASONE VALERATE profile page.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 208204
Tradename:BETAMETHASONE VALERATE
Applicant:Taro Pharm
Ingredient:betamethasone valerate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 208204
Medical Subject Heading (MeSH) Categories for 208204
Suppliers and Packaging for NDA: 208204
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 208204 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4188 51672-4188-3 1 CAN in 1 CARTON (51672-4188-3) > 50 g in 1 CAN
BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 208204 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4188 51672-4188-7 1 CAN in 1 CARTON (51672-4188-7) > 100 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.12%
Approval Date:May 24, 2017TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Cantor Fitzgerald
Daiichi Sankyo
Citi
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.